Worse outcomes were especially noticed in IDH-wt GBM (p < 0.001) (Figure 2A) and IDH-mutant 1p/19q oligodendrogliomas (grade 3) (p = 0.002) (Figure 2B). This evidence concerns the gene IDH1 and glioblastoma.